Definitive Contract HR001116C0124
Award Date
7/26/16
Potential Completion Date
12/31/17
Potential Value
$750K
Federal Agency
Defense Advanced Research Projects Agency
Awardee
Design-Zyme LLC
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AD91 - R&D- Defense Other: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, KS 66046, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $149,661.75 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer. The contract is for the development of a next-generation cell-free prototyping and biomanufacturing platform. Biodiscovery LLC, a subsidiary of the Japanese chemical company Daicel Corporation, specializes in custom molecular...
This is a $4,797,261 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston. The contract is for DARPA's "SUPERB: SYNBIO + UNIVERSAL PURIFICATION OF EXTRACT-DERIVED, RIGHT-ON-TIME BIOLOGICS" program, which aims to develop technologies enabling immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week....
This is a $1,509,995.97 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Enevolv, Inc., a small business subsidiary of Zymergen Inc. The contract is for the development of "Programmable Allosteric Transcription Factors as Specific Molecular Sensor-Actuators" under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a completion date of July 1, 2019 and was set aside for total small business participation.
This is a $963,686.00 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to The Charles Stark Draper Laboratory, Inc. (Draper) to pursue high-risk, high-payoff research initiatives across a broad spectrum of science and engineering disciplines. The effort aims to transform these initiatives into important, radically new, game-changing technologies for U.S. national security. The contract does not have a set-aside designation. Under this contract, Draper...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
This is a $10,846,804.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Leidos, Inc. for a DARPA research project. The contract has no set-aside designation. Major subcontractors include the University of Hawaii, J. Craig Venter Institute, Inc., Signature Science LLC, and Monell Chemical Senses Center. This contract appears to support DARPA's research mission, likely involving work in areas such as synthetic biology, microbial communities, and...
<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>
This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...
The U.S. Defense Threat Reduction Agency (DTRA) awarded a $1,507,783.93 Small Business Innovation Research (SBIR) Phase II contract to Arzeda Corp to conduct research on the "Computational Design of Enzymatic Prophylactics and/or Therapeutics for Chemical Warfare Nerve Agents." This definitive, firm-fixed-price contract has an ultimate completion date of August 28, 2025. The SBIR program provides funding to small businesses to conduct research and development that has the potential for...